Methods of providing solriamfetol therapy to subjects with impaired renal function | Patent Publication Number 20230310362

US 20230310362 A1
Patent NumberUS 11969404 B2
Application Number18295138
Filled DateApr 3, 2023
Priority DateMar 19, 2020
Publication DateOct 5, 2023
Original AssigneeAxsome Therapeutics Inc.
Current AssigneeAxsome Therapeutics Inc.
Inventor/ApplicantsKatayoun Zomorodi
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.